Physician profile
Robert Stephen Ellis
NPI 1093864027
$3,827.43
in general payments reported to CMS, 2019-2025
14 companies · $3,179 in 2025
The $3,179 reported for 2025 was more than what 82% of Trauma Surgery providers received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $32.12 · 2020: $94.74 · 2021: $49.00 · 2022: $261 · 2023: $141 · 2024: $70.08 · 2025: $3,179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,500 · Travel and Lodging: $537 · Food and Beverage: $354.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,500.00 |
| Travel and Lodging | $536.78 |
| Food and Beverage | $353.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,162.61 | 2025 | |
| Ethicon US, LLC | $187.32 | 2020-2024 | Echelon; Endopath, Evarrest, Enseal |
| Shionogi INC | $128.18 | 2022-2023 | Fetroja |
| Takeda Pharmaceuticals U.S.A., INC. | $93.02 | 2022-2024 | Gattex |
| Depuy Synthes Sales INC. | $90.23 | 2021-2022 | |
| Tela Bio, INC. | $42.69 | 2020 | |
| Baudax Bio INC. | $21.36 | 2021 | |
| Kerecis Limited | $17.98 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Misonix INC | $16.95 | 2019 | |
| Lifenet Health | $16.67 | 2025 | Theragenesis Wound Matrix |
| Romark Laboratories, Lc | $15.17 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $15.15 | 2022 | |
| Kls-Martin L.P. | $12.52 | 2020 | |
| Thd America, INC. | $7.58 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Ellis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.